Author:
Nagaratnam Nages,Nagaratnam Kujan,Cheuk Gary
Publisher
Springer International Publishing
Reference39 articles.
1. Kilpivaara O, Levine RL. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science. Leukaemia. 2008;22(10):1813–7.
2. Vainchenker W, Delhommeau F, Constntinescu SN, Bernard OA. New mutations and pathogenesis of myeloproliferative neoplasms. Blood. 2011;118(7):1723–1735.
3. Kico JM, Vij R, Kreisel FH, Hassan, Frater JL. Molecular pathology of myeloproliferative neoplasms. Am J Clin Pathol. 2010:133:602–615.doi:10.1309/AJCPPPZIWFVGNE4A
4. Wadleigh M, Teferi A. Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organisation criteria. Int J Hamatol. 2010;91(2(:174–9.
5. Schmidt AE, Oh ST. Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Am J Clin Pathol. 2012;138(1):12–9.